Conversion Labs CVLB shares are trading higher Monday after Capital Market Laboratories (CML Pro) on Saturday added the company as a company to watch. Citron Research also said said it was long CVLB "and said it's "[n]ew presentation [is] compelling."
Conversion Labs is a health and wellness-focused e-commerce company with a portfolio of online direct-to-consumer brands. The company's portfolio of brands includes proprietary over-the-counter products as well as prescription medications. The company also provides online physician consultations directly to consumers.
Conversion Labs shares were trading up 13.64% at $23.66. The stock has a 52-week high of $25.51 and a 52-week low of 50 cents.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
